India’s medical devices industry set to grow fivefold by 2030: Dr Raghuvanshi at PHDCCI
DCGI Dr Rajeev Singh Raghuvanshi outlines growth potential and regulatory advancements at PHDCCI conference
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drug Controller General of India (DCGI)
NIRMACOM’ by Hetero gets WHO Prequalification for COVID-19 treatment
Hetero’s ‘NIRMACOM’ (Nirmatrelvir), a generic version of Pfizer’s COVID-19 oral antiviral drug ‘PAXLOVID’is co-packaged with…
DCGI approves three COVID vaccines for kids aged above five years
The approval has been granted to covaxin, ZyCov-D and Corbevax
Jubilant Generics gets nod to manufacture, market anti-viral drug Remdesivir
Jubilant Generics recently got an approval from the CDSCO which will further increase capacity of production of Remdesivir in…
Mylan to launch COVID-19 remdisivir drug in India for Rs 4,800
Secures regulatory approval for Remdesivir Lyophilsed Powder for injection 100 mg/vial in India
Mylan announced that the Drug…